BeBetter Med Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Vol. 1Y

—

Shs. 5Y

—

Rev. 5Y

Div Yld LY

—

Div Yld TTM

—

Revenues

Net income

CFO

No notes on this company yet

Write a private note on this company, for your eyes only

Xiong Cai

Senior Deputy General Manager- Chemical Drug Discovery, Director · since 2022

Xinjian Liu

Chief Scientific Officer, Deputy General Manager - Biopharmaceutical Discovery

Changgeng Qian

Chairman of the Board, General Manager

Yajie Cao

Deputy General Manager - Clinical Operations

Tianyi Zhang

Finance Director, Secretary of the Board

URL

IPO date

Oct 28, 2025

Employees

Domiciled in

Incorporated in

No data to show